CSIMarket
 


Genetic Technologies Limited  (GENE)
Other Ticker:  
 

Genetic Technologies Limited's Tangible Leverage Ratio

GENE's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




GENE Tangible Leverage Ratio (Jun 30 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2018)
IV. Quarter
Y / Y Tangible Equity Change -62.41 % -62.41 % -62.41 % -62.41 % -
Y / Y Total Liabilities Change 2.73 % 2.73 % 2.73 % 2.73 % -
Tangible Leverage Ratio MRQ 0.84 0.84 0.84 0.84 0.31
Overall Ranking # # # # #
Seq. Tangible Equity Change 0 % 0 % 0 % -62.41 % 0 %
Seq. Total Liabilities Change 0 % 0 % 0 % 2.73 % 0 %



Tangible Leverage Ratio forth quarter 2019 Comment
Due to repayements of liabilities of 0% Genetic Technologies Limited improved Tangible Leverage Ratio in forth quarter 2019 to 0.84, a new company high.

Within Biotechnology & Pharmaceuticals industry Genetic Technologies Limited achieved lowest Tangible Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is GENE Market Share?
Tangible Leverage Ratio forth quarter 2019 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market # 0


Tangible Leverage Ratio Statistics
High Average Low
0.84 0.58 0.31
(Jun 30 2019)   (Jun 30 2018)




Financial Statements
Genetic Technologies Limited's Tangible Equity $ 2 Millions Visit GENE's Balance sheet
Genetic Technologies Limited's Total Liabilities $ 1 Millions Visit GENE's Balance sheet
Source of GENE's Sales Visit GENE's Sales by Geography


Cumulative Genetic Technologies Limited's Tangible Leverage Ratio

GENE's Tangible Leverage Ratio for the trailling 12 Months

GENE Tangible Leverage Ratio

(Jun 30 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2018)
IV. Quarter
Y / Y Tangible Equity TTM Growth -62.41 % -62.41 % -62.41 % -62.41 % -
Y / Y Total Liabilities TTM Growth 2.73 % 2.73 % 2.73 % 2.73 % -
Tangible Leverage Ratio TTM 0.84 0.59 0.45 0.37 0.31
Total Ranking TTM # # # # #
Seq. Tangible Equity TTM Growth 0 % 0 % 0 % -62.41 % 0 %
Seq. Total Liabilities TTM Growth 0 % 0 % 0 % 2.73 % 0 %


TTM Tangible Leverage Ratio Comment
On the trailing twelve months basis Despite of the repayements of liabilities of 0% in IV. Quarter, Tangible Leverage Ratio improved to 0.84, above Genetic Technologies Limited's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry GENE recorded the lowest Tangible Leverage Ratio. While total ranking remained unchanged compare to previous quarter at no. 0.

Explain Tangible Leverage Ratio?
What is GENE Market Share?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market # 0


TTM Tangible Leverage Ratio Statistics
High Average Low
0 0 0
 




Companies with similar Tangible Leverage Ratio in the quarter ending Jun 30 2019, within Biotechnology & Pharmaceuticals Industry Tangible Leverage RatioJun 30 2019 MRQ Total LiabilitiesJun 30 2019 MRQ Tangible Equity
Htg Molecular Diagnostics Inc  2.01 $ 23.455  Millions$ 11.670  Millions
United Health Products Inc   2.01 $ 0.290  Millions$ 0.145  Millions
Central Garden and Pet Co  1.68 $ 1,031.273  Millions$ 613.740  Millions
Nanostring Technologies Inc   1.67 $ 143.395  Millions$ 85.988  Millions
Collplant Biotechnologies Ltd   1.63 $ 6.664  Millions$ 4.088  Millions
Educational Development Corporation  1.48 $ 39.761  Millions$ 26.871  Millions
Avanos Medical Inc   1.46 $ 491.800  Millions$ 336.100  Millions
Energy Focus Inc  1.42 $ 8.717  Millions$ 6.152  Millions
Conformis inc   1.33 $ 36.297  Millions$ 27.252  Millions
Pacific Biosciences Of California Inc   1.25 $ 94.828  Millions$ 75.754  Millions
Armata Pharmaceuticals Inc   1.24 $ 11.022  Millions$ 8.884  Millions
Neurocrine Biosciences Inc   1.21 $ 583.155  Millions$ 483.706  Millions
Jounce Therapeutics inc   1.12 $ 100.540  Millions$ 90.064  Millions
Coherent Corp   1.10 $ 835.447  Millions$ 760.458  Millions
Edwards Lifesciences Corporation  1.07 $ 2,073.200  Millions$ 1,940.800  Millions
Lsi Industries Inc   1.06 $ 81.163  Millions$ 76.917  Millions
Tracon Pharmaceuticals inc   0.96 $ 8.566  Millions$ 8.919  Millions
Meiragtx Holdings Plc  0.95 $ 123.513  Millions$ 129.563  Millions
Alector Inc   0.94 $ 231.535  Millions$ 245.716  Millions
Repligen Corp  0.88 $ 165.803  Millions$ 188.977  Millions
Spark Therapeutics Inc   0.87 $ 348.648  Millions$ 400.414  Millions
Innate Pharma Sa  0.85 $ 206.018  Millions$ 243.506  Millions
Genetic Technologies Limited  0.84 $ 1.494  Millions$ 1.771  Millions
Editas Medicine inc   0.84 $ 162.563  Millions$ 193.062  Millions
Genocea Biosciences Inc   0.84 $ 32.324  Millions$ 38.438  Millions
Surface Oncology Inc   0.84 $ 70.526  Millions$ 84.322  Millions
Illumina Inc   0.79 $ 2,641.000  Millions$ 3,346.000  Millions
Align Technology inc   0.75 $ 972.335  Millions$ 1,294.830  Millions
Rewalk Robotics Ltd   0.73 $ 12.665  Millions$ 17.268  Millions
Natural Health Trends Corp   0.73 $ 56.739  Millions$ 77.588  Millions

Date modified: 2022-08-31T08:21:00+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NTRB's Profile

Stock Price

NTRB's Financials

Business Description

Fundamentals

Charts & Quotes

NTRB's News

Suppliers

NTRB's Competitors

Customers & Markets

Economic Indicators

NTRB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071